Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-01-01

Study Completion Date

2019-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study of immunosuppression biomarkers in patients with ARDS or cardiogenic shock with ECMO / ECLS, compared to patients with ARDS or cardiogenic shock without ECMO / ECLS

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evolution of the Lymphocyte Phenotype in Patients with Infection in Intensive Care Unit

NCT06415474

Patients Undergoing Esophagectomy Patients with Severe Polytrauma Patients with Severe Neurological Lesion +1 more

RECRUITING NA

Study of Immunosuppression Biomarkers Acquired in Patients Hospitalized in Intensive Care Unit

NCT02881268

Patient Hospitalized in Intensive Care Unit

COMPLETED

IMMUNOREA - Immunological and Inflammatory Determinants Associated With the Prognosis of Intensive Care Patients

NCT07345169

Critical Illness Intensive Care Patients Critical Illness Requiring Intensive Care - Sepsis +3 more

RECRUITING

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

NCT03355625

Extracorporeal Membrane Oxygenation Platelet Activation Platelet Aggregation +3 more

COMPLETED

Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation (Observational Study)

NCT03642912

Coagulation and Hemorrhagic Disorders Extracorporeal Membrane Oxygenation Complication

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Respiratory Distress Syndrome Cardiogenic Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ECMO / ECLS

Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS

Blood test

Intervention Type BIOLOGICAL

No ECMO / ECLS

Patients hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS

Blood test

Intervention Type BIOLOGICAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood test

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient older than 18 years old
* Patient hospitalized in an intensive care unit
* Patient whose initial ARDS or Cardiogenic shock began less than 5 days before admission
* Patients hospitalized for ARDS or Cardiogenic shock with ECMO / ECLS or - Patients hospitalized for ARDS or Cardiogenic shock without ECMO / ECLS

Exclusion Criteria

* Opposition of patient, relative or legal representative for participation in the study
* Pregnant woman
* Pre-immunodepression
* Implementation of immunosuppressive therapy such as chemotherapy, cyclophosphamide, high-dose corticosteroids (\> 0.5mg / kg / day).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No